Genepharm’s product range is the core strategy around which all the other strategic elements revolve. Over the next three years, Genepharm’s product range will grow to encompass the top generic pharmaceuticals that will be dispensed in Australia.

Genepharm's sales and marketing strategy is built around mutual value creation with pharmacy. The four pillars of this strategy are:

Service

Genepharm have built direct sales relationships with Australian pharmacies through the Company’s sales representatives. Our field personnel are not only involved in stock management and product ordering for pharmacists but also provide product information, training and business support.

Profit

Genepharm’s access to an efficient and cost effective product pipeline ensures that products are supplied to the Australian market at prices that provide sustainable financial benefits to pharmacists, patients and the PBS.

Patient Care

Programs that support quality use of medicines and patient confidence in the quality, safety and efficacy of generic medicines are currently being developed by Genepharm with community pharmacists. Genepharm’s patient care focus is prevalent in patient friendly packaging and product, designed to make the use of Genepharm generics easy and safe.

Equity

Genepharm’s unique proposition of mutual value creation between the business and its pharmacy customers is built on a product offer that includes not only appropriate pricing incentives but long term equity incentives to include all stakeholders in the value growth of the business.